Difficulty: Medium
Average Score: 68%
Testbank
A nurse is caring for a patient whose diagnosis of multiple myeloma is being treated with bortezomib. The nurse should assess for what adverse effect of this treatment?
Correct answer
D
Rationale
Peripheral neuropathy is a common adverse effect associated with bortezomib treatment in patients with multiple myeloma.
Bortezomib can cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, and pain in the extremities. This side effect can significantly impact the patient's quality of life and may require intervention or dose adjustment during treatment.
A: Stomatitis may occur in cancer treatments but is not a primary concern with bortezomib specifically, as it is more commonly associated with chemotherapy agents that directly affect mucosal tissues.
B: Nephropathy is a potential risk in some cancer therapies, but bortezomib does not primarily cause renal impairment, making it less relevant in this context.
C: Cognitive changes can occur in cancer patients; however, they are not a well-documented direct adverse effect of bortezomib, which primarily affects peripheral nerves rather than cognitive function.
Bortezomib can cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, and pain in the extremities. This side effect can significantly impact the patient's quality of life and may require intervention or dose adjustment during treatment.
A: Stomatitis may occur in cancer treatments but is not a primary concern with bortezomib specifically, as it is more commonly associated with chemotherapy agents that directly affect mucosal tissues.
B: Nephropathy is a potential risk in some cancer therapies, but bortezomib does not primarily cause renal impairment, making it less relevant in this context.
C: Cognitive changes can occur in cancer patients; however, they are not a well-documented direct adverse effect of bortezomib, which primarily affects peripheral nerves rather than cognitive function.